Search Results - "Moriarty, Linda"

Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer by Rehman, Hasan, Chi, Jeffrey, Hakim, Nausheen, Goyal, Shreya Prasad, Olazagasti, Coral, Jose, Jyothi, Moriarty, Linda, Saif, Muhammad Wasif

“…Background: Treatment with gemcitabine/nab-paclitaxel confers a survival benefit over gemcitabine monotherapy in patients with advanced pancreatic cancer…”
Get full text

FOLFIRINOX versus sequential 5-FU, oxaliplatin, and irinotecan-based regimens in patients with recurrent pancreatic cancer (rPDAC) by Rehman, Hasan, Chi, Jeffrey, Hakim, Nausheen, Jose, Jyothi, Moriarty, Linda, Lamont, Carol, Saif, Wasif M.

“…Abstract only e16791 Background: There is a paucity of data to guide treatment for rPDAC after curative resection and gemcitabine-based adjuvant chemotherapy…”
Get full text

A prospective pilot study of pharmacogenetic-based dosing of 5-fluouracil (5-FU) and irinotecan (IRI) in patients (pts) with gastrointestinal (GI) malignancies by Chi, Jeffrey, Hakim, Nausheen, Rehman, Hasan, Moriarty, Linda, Maloney, Antonia, Smith, Melissa H, Jose, Jyothi, Saif, Wasif M.

“…Abstract only e16138 Background: 5-FU and IRI are core components of chemotherapies for GI malignancies. Previous studies have shown that mutations in DPYP and…”
Get full text

Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged > 65 years with advanced pancreatic cancer (APC) by Rehman, Hasan, Chi, Jeffrey, Hakim, Nausheen, Goyal, Shreya Prasad, Olazagasti, Coral, Jose, Jyothi, Moriarty, Linda, Saif, Wasif M.

“…Abstract only 705 Background: Treatment with gemcitabine/nab-paclitaxel confers a survival benefit over gemcitabine monotherapy in APC. However, such treatment…”
Get full text

First analysis of same-day pegfilgrastim use with concurrent capecitabine-based regimens in pts with GI malignancies by Hakim, Nausheen, Chi, Jeffrey, Rehman, Hasan, Goyal, Shreya Prasad, Olazagasti, Coral, Moriarty, Linda, Jose, Jyothi, Lamont, Carol, Saif, Wasif M.

“…Abstract only 817 Background: Pegfilgastrim is administered 24 hrs after chemotherapy to reduce risks of myelosuppression. This requires an additional clinic…”
Get full text

Safety and efficacy of biweekly gemcitabine in combination with capecitabine (GemCap) in elderly and frail patients (pts) with resected pancreatic cancer (PC) by Hakim, Nausheen, Chi, Jeffrey, Rehman, Hasan, Nealon, William, Deutsch, Gary B, Newman, Elliot, Anantha, Sandeep, Coppa, Gene, Deperalta, Danielle, Rishi, Arvind, Maloney, Antonia, Moriarty, Linda, Smith, Melissa H, Jose, Jyothi, Saif, Wasif M.

“…Abstract only 4628 Background: ESPAC-4 study showed that GemCap conferred a survival benefit over gemcitabine monotherapy in resected PC patients. ESPAC-4…”
Get full text

Ambulatory oncology nurses making the right call: assessment and education in telephone triage practices by Gleason, Karen, O'Neill, Eileen Brennan, Goldschmitt, Jennifer, Horigan, Jennifer, Moriarty, Linda

“…Nurses in a hematology/oncology practice are responsible for the triage and management of phone calls from a diverse oncology population. An initiative was…”
Get full text